Anne Marie Rainey, RN, MSN, CHC As the healthcare delivery and payment system continues the shift from volume-based to value-based care, providers, support staff, and administrators have a responsibility to…
Swapna Johncy, APRN Chimeric antigen receptor (CAR)-T cell therapy is a new class of cellular immunotherapies that involves ex vivo genetic modification of T cells to incorporate an engineered CAR.…
The Oncology Connection Fam-trastuzumab-deruxtecan-nxki (Enhertu, Daiichi-Sankyo/AstraZeneca), or T-DXd, led to a high intracranial response rate in patients with active brain metastases from human epidermal growth factor receptor 2 (HER2)-positive breast…
The Oncology Connection Patients and oncologists experience nonmedical switching from one trastuzumab biosimilar to another in different ways, pointing to a need for oncology providers to find more effective ways…
Sijimol Mathew, DNP, APRN The patient with cancer has many risk factors for developing lactic acidosis. The diagnosis of cancer itself contributes to the overproduction of lactate caused by thiamine…
Beth Sandy, MSN, CRNP Sharon is a 55-year-old woman with limited-stage small cell lung cancer (SCLC). She is in the emergency room (ER) at her local hospital due to dehydration…
The Oncology Connection Oncology associations are advising practices to carefully weigh the risks and benefits of participating in a new alternative payment model by the Centers for Medicare and Medicaid…
The Oncology Connection Acceptance and commitment therapy (ACT) provided benefits to patients with advanced lung cancer but did not have a significant effect on fatigue interference, according to a pilot…